翻訳と辞書 |
PL-6983
PL-6983 is a selective MC4 receptor agonist which is under development by Palatin Technologies for the treatment of female sexual dysfunction and erectile dysfunction. It was developed as a successor to/replacement of bremelanotide (PT-141) due to concerns of a side effect of increased blood pressure seen with the latter in clinical trials.〔〔 Relative to bremelanotide, PL-6983 produces significantly lower increases in blood pressure in animal models.〔〔 ==See also==
* PF-00446687 * THIQ * Melanotan II
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「PL-6983」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|